This study compares conventional hazard ratios and an alternative, clinically interpretable approach to quantify the long-term survival benefit in patients receiving chemotherapy with immunotherapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145678 | PMC |
| http://dx.doi.org/10.1001/jamaoncol.2018.0518 | DOI Listing |
Publication Analysis
Top Keywords
long-term survival
8
survival benefit
8
quantification long-term
4
benefit comparative
4
comparative oncology
4
oncology clinical
4
clinical study
4
study study
4
study compares
4
compares conventional
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!